GOBIOM is a comprehensive repository of biomarkers reported in Pre-clinical, Clinical and Exploratory phases.
Each biomarker is linked to its therapeutic area, target and drug. GOBIOM contains information on Biochemical, Genomic, Imaging, Metabolite, Clinical Scoring Scales and Cellular Markers for 18 different therapeutic areas covering 1,800 plus therapeutic indications.
The biomarkers have reported utilities for diagnosis, prognosis, monitoring disease progression, treatment response, surrogate, efficacy and toxicity.
GOBIOM is developed in collaboration with the USFDA and a big pharma.
GOBIOM curates all information manually with controlled ontology from: